Clinical trial
Antioxidant Therapy to Reduce Inflammation in Sickle Cell Disease
NCT01054768 is registered in ClinicalTrials.gov with UCSF Benioff Children's Hospital Oakland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Antioxidant Therapy to Reduce Inflammation in Sickle Cell Disease
- Lead sponsor
- UCSF Benioff Children's Hospital Oakland
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 31, 2009
- Completion date
- April 30, 2013
- Enrollment
- 37 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.